N. Dolgova, A. Ryndich, A. Suladze, T. Tverdokhlebova, A. Matuzkova, K. Bolatchiev, L.F. Chernigovec
{"title":"Some clinical and epidemiological aspects of the course of COVID-19 in people living with HIV","authors":"N. Dolgova, A. Ryndich, A. Suladze, T. Tverdokhlebova, A. Matuzkova, K. Bolatchiev, L.F. Chernigovec","doi":"10.33029/2305-3496-2022-11-1-41-46","DOIUrl":null,"url":null,"abstract":"Objective. To describe the clinical and epidemical characteristics of a new coronavirus disease 2019 (COVID-19) in people living with HIV, for HIV infection implies the development of an immunosuppressive condition that may exacerbate the course of COVID-19. Material and methods. The research is based on retrospective and current epidemiological situation of HIV and SARS-CoV-2 infections in the Southern Russia regions during 2020 and survey of the patients with the co-infections concerning epidemiological, clinical, and laboratory diagnostic information. We collected all data from 15 regional centers for AIDS prevention and control in the Southern and North Caucasus Federal Districts. The survey sample consists of 121 patients. Statistical computation is done with Microsoft Office Excel 2010. Results and discussion. HIV patients of various age and social characteristics are involved in the COVID-19 epidemic process. Within registered HIV and SARS-CoV-2 co-infections all patients have apparent clinical symptoms. Asymptomatic cases are not presented. Mild cases prevail in the sample (48.8%). The frequency of severe and extremely severe was significantly higher in people living with HIV/AIDS on ART more than 2 months against naive PLHIV or using ART up two one month (р<0.05). © 2022 by the authors.","PeriodicalId":36113,"journal":{"name":"Infectious Diseases: News, Opinions, Training","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Infectious Diseases: News, Opinions, Training","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33029/2305-3496-2022-11-1-41-46","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Social Sciences","Score":null,"Total":0}
引用次数: 2
艾滋病毒感染者COVID-19病程的一些临床和流行病学方面
目标。为了描述2019年新型冠状病毒病(COVID-19)在艾滋病毒感染者中的临床和流行特征,因为艾滋病毒感染意味着出现可能加剧COVID-19病程的免疫抑制状况。材料和方法。该研究基于2020年俄罗斯南部地区HIV和SARS-CoV-2感染的回顾性和当前流行病学情况,以及对合并感染患者的流行病学、临床和实验室诊断信息的调查。我们从南高加索和北高加索联邦区的15个艾滋病预防和控制区域中心收集了所有数据。调查样本包括121例患者。统计计算使用Microsoft Office Excel 2010完成。结果和讨论。不同年龄和社会特征的HIV患者参与了COVID-19的流行过程。在登记的HIV和SARS-CoV-2合并感染病例中,所有患者均有明显的临床症状。没有出现无症状的病例。病例以轻症为主(48.8%)。在接受抗逆转录病毒治疗2个月以上或接受抗逆转录病毒治疗2个月以上的艾滋病毒/艾滋病感染者中,严重和极严重的频率显著高于对照组(p <0.05)。©2022作者所有。
本文章由计算机程序翻译,如有差异,请以英文原文为准。